Beta-blockers in cirrhosis: therapeutic window or an aspirin for all?

J Hepatol. 2014 Aug;61(2):449-50. doi: 10.1016/j.jhep.2014.03.038. Epub 2014 Apr 24.

Authors

Alberto Ferrarese¹, Emmanuel Tsochatzis², Andrew Kenneth Burroughs², Marco Senzolo³

Affiliations

¹ Multivisceral Transplant Unit, Department of Surgery Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
² Sheila Sherlock Liver Centre, Royal Free Hospital and UCL Institute of Liver and Digestive Health, London, UK.
³ Multivisceral Transplant Unit, Department of Surgery Oncology and Gastroenterology, Padua University Hospital, Padua, Italy. Electronic address: [email protected].

PMID: 24768827
DOI: 10.1016/j.jhep.2014.03.038

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Humans
Liver Cirrhosis / drug therapy*

Substances

Adrenergic beta-Antagonists